Navigation Links
CSHL scientists identify a new strategy for interfering with a potent cancer-causing gene
Date:2/11/2013

Cold Spring Harbor, N.Y. Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics.

CSHL Assistant Professor Christopher Vakoc, M.D., Ph.D., and colleagues, including the group of Professor Robert Roeder Ph.D. at The Rockefeller University, report the characterization of a protein required for AML in a paper published today in the Proceedings of the National Academy of Sciences.

Screening of DNA packaging proteins calls attention to RNF20

About 5%-10% of AML is characterized by the rearrangement of a gene called MLL (Mixed-Lineage Leukemia). The MLL fusion proteins that result from this rearrangement are potent oncogenes -- cancer-causing genes. They are particularly common in infant acute leukemia, which is usually resistant to standard chemotherapy.

An emerging body of evidence implicates problems with chromatin, the packaging material for DNA within the cell nucleus, as a major cause of acute leukemia. Based on this, Vakoc's laboratory is searching for novel drug targets among chromatin proteins, with the hope of identifying new ways to fight this disease.

"We sifted through a class of proteins that add 'protein tags' to chromatin in a search for new therapeutic targets", says Eric Wang, a former technician in the Vakoc lab who led this study. Wang is currently a doctoral student at Johns Hopkins University. These 'protein tags' are called ubiquitin and constitute one of many ways to control which genes are switched 'ON' or 'OFF' in our cells.

The team identified a protein called RNF20 that attaches ubiquitin tags to chromatin as being essential for the formation of leukemias caused by MLL-rearrangements. When they suppressed the expression of RNF20, the res
'/>"/>

Contact: Edward Brydon
ebrydon@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists solving the mystery of human consciousness
2. Scientists uncover multiple faces of deadly breast cancer
3. Scientists identify major source of cells defense against oxidative stress
4. Scientists tailor cell surface targeting system to hit organelle ZIP codes
5. Scientists rewrite rulebook on breast cancer in landmark global study
6. Warwick scientists uncover how checkpoint proteins bind chromosomes
7. NIH scientists link quickly spreading gene to Asian MRSA epidemic
8. Joslin scientists identify important mechanism that affects the aging process
9. Scripps Research scientists show how memory B cells stay in class to fight different infections
10. Scientists Map Melanomas Genome
11. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Plano, Texas (PRWEB) June 03, 2015 ... Intelligence and Analytics solutions, today announced the launch ... Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio. ... embed additional visualization capabilities and advanced functionalities into ... of the DSX suite, Visual BI is adding ...
(Date:6/3/2015)... According to an article published on May14th ... oxycodone pills which actually contained the potent addictive drug ... and even sported the “A/215” imprint common on real ... mg oxycodone to be exceptionally critical of their prescriptions—especially ... illegally on the street. Fentanyl is an opiate-based narcotic ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 These are ... sectors. The ever growing number of digital-first business are ... There is now a serious need for traditional businesses ... way they operate and deliver their services. On ... partnerships between incumbents and technology start-ups, to bring new ...
(Date:6/3/2015)... Hills, Calif. (PRWEB) June 03, 2015 ... most popular boot camp fitness program. The company helps thousands ... healthier lives. To encourage more people to hit the gym ... released these five tips for getting the most out any ... The hardest part about committing to gym memberships is saying ...
(Date:6/3/2015)... June 03, 2015 evigilo, a ... multi-channel solutions, reported of its "behind-the-scenes" involvement in ... few months. Since March this year, an unusual ... inflicting the South-American country, putting millions in danger. ... gas into the atmosphere. "evigilo's technology, adopted by ...
Breaking Medicine News(10 mins):Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2
... physically victimized by peers concludes that one-on-one mentoring about ... them far less likely to become victims again if ... attack. , The research, by investigators at Johns Hopkins ... D.C., was conducted on 10- to 15-year-olds treated for ...
... reveals an important and newly discovered pathway used by ... survive and grow within the very cells meant to ... and vaccines for tuberculosis (TB) and certain other chronic ... supported by the National Institute of Allergy and Infectious ...
... to Ask Voters ... of Health Care, TRENTON, N.J., Nov. 1 Calling themselves ... forces to ask the state,s public policy makers to put health ... level. The First Ladies,joined the newest members of the Partnership to ...
... U.S.-based employers want to continue to provide health care coverage, yet oppose ... prefer a middle ground between the presidential candidates’ health care proposals. ... ... U.S.-based employers want to continue to provide health care coverage, ...
... Alexandria, VA - The American Academy of Otolaryngology ... issue a comprehensive clinical guideline to help healthcare ... positional vertigo (BPPV), one of the most common ... evidence-based recommendations on managing BPPV, the most common ...
... Crisp Autumn Days And Makes Great Holiday Recipes for ... Oct. 31 Full-flavored, Single,Origin Dilmah Tea is the ideal ... sharing with friends or drinking while curled,up with a book. ... and,satisfying hand picked "tea lover" classics from the Dilmah Gourmet ...
Cached Medicine News:Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 2Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 3Health News:Persistent bacterial infection exploits killing machinery of immune cells 2Health News:On Weekend Before the Election, New Jersey's First Ladies Speak Out for Healthcare 2Health News:On Weekend Before the Election, New Jersey's First Ladies Speak Out for Healthcare 3Health News:Employers “Vote” on Presidential Candidates' Health Care Platforms: Prefer Middle Ground Between the Two Approaches 2Health News:Employers “Vote” on Presidential Candidates' Health Care Platforms: Prefer Middle Ground Between the Two Approaches 3Health News:ENT doctors release national guideline on treatment for common cause of dizziness 2Health News:ENT doctors release national guideline on treatment for common cause of dizziness 3Health News:Cook to a Tea 2
(Date:6/3/2015)... 2015 RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapeutics, primarily ... today announced that it received a Notice of ... Trademark Office (USPTO) on its novel, self-delivering ... Interference in Ocular Indications," covers methods of ...
(Date:6/3/2015)... GAITHERSBURG, Md. , June 3, 2015  GenVec, ... collaboration with Dr. David T. Curiel and ... University at St. Louis (WUSTL).  ... Center and the Cancer Biology Division within the Department ... GenVec and the WUSTL team will create modified versions ...
(Date:6/3/2015)... , June 3, 2015  Armetheon, Inc., ... drugs for cardiovascular diseases, today announced that ... appointed Chief Executive Officer, effective immediately. Dr. Kakkar ... global, high-growth enterprises, with a successful track record ... human health. With expertise that includes the development ...
Breaking Medicine Technology:RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ), ... today that the company is partnering with The ... Houston, Texas to launch a prospective,clinical study to ... in the study will be randomly assigned to ...
... announces data presented at AACR-NCI-EORTC ... ... (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a,wholly-owned ... candidates during the 19th annual AACR-NCI-EORTC Symposium. "These studies show ...
Cached Medicine Technology:M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The Precedent establishes a new generation of revision hip stems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
Medicine Products: